Sean Saint - 27 Feb 2026 Form 4/A - Amendment Insider Report for Beta Bionics, Inc. (BBNX)

Reporting relationship: President & CEO, Director
Issuer ticker: BBNX
Reported as of: 27 Feb 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 13 Mar 2026, 16:15:18 UTC
Original report date: 03 Mar 2026
Prior SEC filing: 04 Dec 2025
Next SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephen Feider, Attorney-in-Fact

Key filing fact

Sean Saint filed Form 4/A - Amendment for Beta Bionics, Inc. (BBNX) on 13 Mar 2026.

Key facts

This page summarizes Sean Saint's Form 4/A - Amendment filing for Beta Bionics, Inc. (BBNX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Mar 2026, 16:15.

Change

Previous filing in this sequence was filed on 04 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002048593 Primary reporting owner

Saint Sean

Relationship: President & CEO, Director
Address: C/O BETA BIONICS, INC., 11 HUGHES, IRVINE
Signature: /s/ Stephen Feider, Attorney-in-Fact
Signature date: 13 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BBNX transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +287,944
Change %
Price: $0.000000^*
Shares after: 287,944
Date: 27 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 287,944
Exercise price: $12.63
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026.

SEC remarks

The purpose of this amendment is to correct the number of shares underlying the option grant that was reported on the reporting person's original Form 4 filed with the Securities and Exchange Commission on March 3, 2026.